Top compounds associated with response to MTFR1L


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA Bosutinib GDSC1000 pan-cancer AAC -0.091 0.01
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.097 0.01
mRNA BIBW2992 CTRPv2 pan-cancer AAC -0.094 0.01
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.084 0.01
mRNA Axitinib CTRPv2 pan-cancer AAC 0.087 0.02
mRNA TG-100-115 CTRPv2 pan-cancer AAC 0.094 0.02
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.079 0.02
mRNA Camptothecin GDSC1000 pan-cancer AAC -0.088 0.02
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.081 0.02
Download CSV